Top compounds associated with response to INMT-FAM188B


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.062 0.1
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.058 0.1
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.053 0.1
mRNA CR-1-31B CTRPv2 pan-cancer AAC 0.054 0.1
mRNA COL-3 CTRPv2 pan-cancer AAC 0.06 0.1
mRNA nelarabine CTRPv2 pan-cancer AAC -0.063 0.1
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.1
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.06 0.1
mRNA B02 CTRPv2 pan-cancer AAC -0.059 0.1
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.054 0.1
Download CSV